Signals of adverse drug reactions communicated by pharmacovigilance stakeholders: protocol for a scoping review of the global literature

BACKGROUND: Signals of adverse drug reactions (ADRs) form the basis of some regulatory risk-minimization actions in pharmacovigilance. Reviews of limited scope have highlighted that such signals are mostly supported by reports of ADRs or multiple types of evidence. The time that elapses between a re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sartori, Daniele, Aronson, Jeffrey K., Onakpoya, Igho J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425142/
https://www.ncbi.nlm.nih.gov/pubmed/32791982
http://dx.doi.org/10.1186/s13643-020-01429-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7425142/
https://www.ncbi.nlm.nih.gov/pubmed/32791982
http://dx.doi.org/10.1186/s13643-020-01429-z

Ejemplares similares